- Published:
A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1
Biological Procedures Online volume 6, pages 163–172 (2004)
Abstract
We have established a uniform procedure for the expression and purification of the cyclin-dependent kinases CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1. We attach a His6-tag to one of the subunits of each complex and then co-express it together with the other subunits in Spodoptera frugiperda insect cells. The CDK complexes are subsequently purified by Ni2+-NTA and Mono S chromatography. This approach generates large amounts of active recombinant kinases that are devoid of contaminating kinase activities. Importantly, the properties of these recombinant kinases are similar to their natural counterparts (Pinhero et al. 2004, Eur J Biochem 271:1004–14). Our protocol provides a novel systematic approach for the purification of these three (and possibly other) recombinant CDKs.
Abbreviations
- CDK:
-
cyclin-dependent kinase
- CTD:
-
carboxyl-terminal domain of RNA polymerase II
- Cyc:
-
cyclin
- MBP:
-
myelin basic protein
References
Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. The dynamics of cyclin dependent kinase structure. Annu Rev Cell Dev Biol 1997; 13(6):261–291.
Kobor MS, Greenblatt J. Regulation of transcription elongation by phosphorylation. Biochim Biophys Acta 2002; 1577(2):261–275.
Palancade B, Bensaude O. Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation. Eur J Biochem 2003; 270(19):3859–3870.
Ramanathan YS, Rajpara M, Reza SM, Lees E, Shuman S, Mathews MB, Pe’ery T. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem 2001; 276(14):10913–10920.
Rickert P, Corden JL, Lees E. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 1999; 18(4):1093–1102.
Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 2000; 20(8):2629–2634.
Ping YH, Rana TM. Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes. J Biol Chem 1999; 274(11):7399–7404.
Nigg EA. Cyclin-dependent kinase-7 – at the cross-roads of transcription, DNA-repair and cell-cycle control. Curr Opin Cell Bio 1996; 8(3):312–317.
Rochette-Egly C, Adam S, Rossignol M, Egly JM, Chambon P. Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 1997; 90(1):97–107.
Bastien J, Adam-Stitah S, Riedl T, Egly JM, Chambon P, Rochette-Egly C. TFIIH interacts with the retinoic acid receptor gamma and phosphorylates its AF-1-activating domain through cdk7. J Biol Chem 2000; 275(29):21896–21904.
Chen D, Riedl T, Washbrook E, Pace PE, Coombes RC, Egly JM, Ali S. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell 2000; 6(1):127–137.
Inamoto S, Segil N, Pan ZQ, Kimura M, Roeder RG. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J Biol Chem 1997; 272(47):29852–29858.
Ko LJ, Shieh SY, Chen X, Jayaraman L, Tamai K, Taya Y, Prives C, Pan ZQ. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol 1997; 17(21):7220–7229.
Pinhero R, Liaw P, Bertens K, Yankulov K. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II. Eur J Biochem 2004; 271(5):1004–1014.
Peng J, Zhu Y, Milton JT, Price DH. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 1998; 12(5):755–762.
Richardson CD, Banville M, Lalumiere M, Vialard J, Meighen EA. Bacterial luciferase produced with rapid-screening baculovirus vectors is a sensitive reporter for infection of insect cells and larvae. Intervirology 1992; 34(4):213–227.
Fisher R, Jin P, Chamberlin H, Morgan D. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 1995; 83(1):47–57.
Yankulov KY, Bentley DL. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. Embo J 1997; 16(7):1638–1646.
Kikkawa U, Minakuchi R, Takai Y, Nishizuka Y. Calciumactivated, phospholipid-dependent protein kinase (protein kinase C) from rat brain. Methods Enzymol 1983; 99:288–298.
Rossignol M, Egly JM. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. Embo J 1997; 16(7):1628–1637.
Fisher RP, Morgan DO. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 1994; 78(4):713–724.
Larochelle S, Chen J, Knights R, Pandur J, Morcillo P, Erdjument-Bromage H, Tempst P, Suter B, Fisher RP. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. Embo J 2001; 20(14):3749–3759.
Ljungman M, Paulsen MT. The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382. Mol Pharmacol 2001; 60(4):785–789.
Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother 2002; 50(6):779–792.
Taylor SL, Kinchington PR, Brooks A, Moffat JF. Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J Virol 2004; 78(6):2853–2862.
Sano M, Abdellatif M, Oh H, Xie M, Bagella L, Giordano A, Michael LH, DeMayo FJ, Schneider MD. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat Med 2002; 8(11):1310–1317.
Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, Brady JN. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol 2000; 20(14):5077–5086.
Dubois MF, Vincent M, Vigneron M, Adamczewski J, Egly JM, Bensaude O. Heat-shock inactivation of the tfiih-associated kinase and change in the phosphorylation sites on the c-terminal domain of RNA-polymerase-II. Nucleic Acids Research 1997; 25:694–700.
Yee A, Wu L, Liu L, Kobayashi R, Xiong Y, Hall FL. Biochemical characterization of the human cyclin-dependent protein kinase activating kinase. J Biol Chem 1996; 271(1):471–477.
Adamczewski JP, Rossingol M, Tassan JP, Nigg EA, Moncollin V, Egly JM. Mat1, cdk7 and cyclin-H form a kinase complex which is uv light-sensitive upon association with TFIIH. Embo J 1996; 15(8):1877–1884.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: August 18, 2004.
Rights and permissions
About this article
Cite this article
Pinhero, R., Liaw, P. & Yankulov, K. A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1. Biol. Proced. Online 6, 163–172 (2004). https://doi.org/10.1251/bpo86
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1251/bpo86